» Articles » PMID: 35773275

Occlusion of Dopamine-dependent Synaptic Plasticity in the Prefrontal Cortex Mediates the Expression of Depressive-like Behavior and is Modulated by Ketamine

Overview
Journal Sci Rep
Specialty Science
Date 2022 Jun 30
PMID 35773275
Authors
Affiliations
Soon will be listed here.
Abstract

Unpredictable chronic mild stress (CMS) is among the most popular protocols used to induce depressive-like behaviors such as anhedonia in rats. Differences in CMS protocols often result in variable degree of vulnerability, and the mechanisms behind stress resilience are of great interest in neuroscience due to their involvement in the development of psychiatric disorders, including major depressive disorder. Expression of depressive-like behaviors is likely driven by long-term alterations in the corticolimbic system and by downregulation of dopamine (DA) signaling. Although we have a deep knowledge about the dynamics of tonic and phasic DA release in encoding incentive salience and in response to acute/chronic stress, its modulatory action on cortical synaptic plasticity and the following implications on animal behavior remain elusive. Here, we show that the expression of DA-dependent synaptic plasticity in the medial prefrontal cortex (mPFC) is occluded in rats vulnerable to CMS, likely reflecting differential expression of AMPA receptors. Interestingly, such difference is not observed when rats are acutely treated with sub-anesthetic ketamine, possibly through the recruitment of dopaminergic nuclei such as the ventral tegmental area. In addition, by applying the synaptic activity sensor SynaptoZip in vivo, we found that chronic stress unbalances the synaptic drive from the infralimbic and prelimbic subregions of the mPFC toward the basolateral amygdala, and that this effect is counteracted by ketamine. Our results provide novel insights into the neurophysiological mechanisms behind the expression of vulnerability to stress, as well as behind the antidepressant action of ketamine.

Citing Articles

Boosting Psychotherapy With Noninvasive Brain Stimulation: The Whys and Wherefores of Modulating Neural Plasticity to Promote Therapeutic Change.

Saccenti D, Lauro L, Crespi S, Moro A, Vergallito A, Grgic R Neural Plast. 2024; 2024:7853199.

PMID: 39723244 PMC: 11669434. DOI: 10.1155/np/7853199.


Antidepressant- and Anxiolytic-Like Effect of the Froriepia subpinnata Extract in the Rat: Neurochemical Correlates.

Samandari-Bahraseman M, Esmaeilzadeh-Salestani K, Dogani M, Khaleghdoust B, Hatami N, Esmaeili-Mahani S Brain Behav. 2024; 14(11):e70171.

PMID: 39607287 PMC: 11603432. DOI: 10.1002/brb3.70171.


Epigenetic Modifications and Neuroplasticity in the Pathogenesis of Depression: A Focus on Early Life Stress.

Benatti B, Adiletta A, Sgado P, Malgaroli A, Ferro M, Lamanna J Behav Sci (Basel). 2024; 14(10).

PMID: 39457754 PMC: 11504006. DOI: 10.3390/bs14100882.


An Observational Longitudinal Study on Seasonal Variations in Tourette Syndrome: Evidence for a Role of Ambient Temperature in Tic Exacerbation.

Lamanna J, Mazzoleni R, Farina R, Ferro M, Galentino R, Porta M Biomedicines. 2024; 12(8).

PMID: 39200133 PMC: 11351247. DOI: 10.3390/biomedicines12081668.


Comparison between Single-Dose and Two-Dose Psilocybin Administration in the Treatment of Major Depression: A Systematic Review and Meta-Analysis of Current Clinical Trials.

Salvetti G, Saccenti D, Moro A, Lamanna J, Ferro M Brain Sci. 2024; 14(8).

PMID: 39199520 PMC: 11352277. DOI: 10.3390/brainsci14080829.


References
1.
Bath K, Russo S, Pleil K, Wohleb E, Duman R, Radley J . Circuit and synaptic mechanisms of repeated stress: Perspectives from differing contexts, duration, and development. Neurobiol Stress. 2017; 7:137-151. PMC: 5736942. DOI: 10.1016/j.ynstr.2017.05.001. View

2.
Willner P . Reliability of the chronic mild stress model of depression: A user survey. Neurobiol Stress. 2017; 6:68-77. PMC: 5314419. DOI: 10.1016/j.ynstr.2016.08.001. View

3.
Russo S, Nestler E . The brain reward circuitry in mood disorders. Nat Rev Neurosci. 2013; 14(9):609-25. PMC: 3867253. DOI: 10.1038/nrn3381. View

4.
Holly E, Miczek K . Ventral tegmental area dopamine revisited: effects of acute and repeated stress. Psychopharmacology (Berl). 2015; 233(2):163-86. PMC: 4703498. DOI: 10.1007/s00213-015-4151-3. View

5.
Valenti O, Gill K, Grace A . Different stressors produce excitation or inhibition of mesolimbic dopamine neuron activity: response alteration by stress pre-exposure. Eur J Neurosci. 2012; 35(8):1312-21. PMC: 3335739. DOI: 10.1111/j.1460-9568.2012.08038.x. View